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Astrocyte Reactivity After Brain Injury—
The Role of Galectins 1 and 3
Swetlana Sirko,1,2 Martin Irmler,3 Sergio Gascon,1,2 Sarah Bek,1 Sarah Schneider,1,2
Leda Dimou,1,2 Jara Obermann,4 Daisylea De Souza Paiva,1,5 Francoise Poirier,6
Johannes Beckers,3,7 Stefanie M. Hauck,4 Yves-Alain Barde,8 and Magdalena G€otz1,2,9
Astrocytes react to brain injury in a heterogeneous manner with only a subset resuming proliferation and acquiring stem cell
properties in vitro. In order to identify novel regulators of this subset, we performed genomewide expression analysis of reac-
tive astrocytes isolated 5 days after stab wound injury from the gray matter of adult mouse cerebral cortex. The expression
pattern was compared with astrocytes from intact cortex and adult neural stem cells (NSCs) isolated from the subependymal
zone (SEZ). These comparisons revealed a set of genes expressed at higher levels in both endogenous NSCs and reactive
astrocytes, including two lectins—Galectins 1 and 3. These results and the pattern of Galectin expression in the lesioned brain
led us to examine the functional significance of these lectins in brains of mice lacking Galectins 1 and 3. Following stab wound
injury, astrocyte reactivity including glial fibrillary acidic protein expression, proliferation and neurosphere-forming capacity
were found significantly reduced in mutant animals. This phenotype could be recapitulated in vitro and was fully rescued by
addition of Galectin 3, but not of Galectin 1. Thus, Galectins 1 and 3 play key roles in regulating the proliferative and NSC
potential of a subset of reactive astrocytes.
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Introduction
Reactive gliosis is a widespread reaction of glial cells topathological processes in the brain. It involves astrocytes,
NG2 glia, and microglia that mediate beneficial and adverse
effects, such as wound closure and scar formation, respectively
(Kettenmann et al., 2011). Recent work indicates a striking
heterogeneity in the reaction of each type of glial cells
(Anderson et al., 2014; Burda and Sofroniew, 2014; Dimou
and G€otz, 2014). This could be best demonstrated by live in
vivo imaging, which revealed a surprisingly heterogeneous
reaction of astrocytes reacting to stab wound injury in the
adult murine cerebral cortex gray matter (GM), with some
astrocytes hardly reacting at all, others polarizing toward the
injury site and yet others proliferating and generating two
daughter astrocytes (Bardehle et al., 2013). Furthermore, clo-
nal analysis demonstrated that the differential reaction of
astrocyte subtypes is seemingly related to their distinct devel-
opmental origin (Martın-Lopez et al., 2013). In view of this
heterogeneity, it is now important to address the mechanisms
regulating the reaction of these distinct astrocyte subsets after
brain injury.
Astrocytes resuming cell division after lesion are of particu-
lar importance, as proliferation is the only means to increase
astrocyte numbers at the injury site in the cerebral cortex GM
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(Bardehle et al., 2013). Indeed, proliferating astrocytes are critical
for restricting the injury size and the number of infiltrating cells
and inflammation, since their elimination has been shown to
aggravate brain damage after lesion (Burda and Sofroniew,
2014). Interestingly, astrocyte proliferation in the GM is highly
injury-dependent and does not occur upon amyloid plaque dep-
osition or even pronounced neuronal cell death, in spite of pro-
found microglia activation and proliferation (Behrendt et al.,
2013; Sirko et al., 2013). Instead, it is selectively elicited upon
injury involving alterations of the blood brain barrier, such as
traumatic, ischemic, and demyelinating injuries (Behrendt et al.,
2013; Dimou and G€otz, 2014; Gadea et al., 2008; G€otz and
Sirko, 2013; Kamphuis et al., 2012). These injury-specific differ-
ences led to the identification of signals regulating reactive astro-
cyte proliferation, including endothelin-1, sonic hedgehog and
fibroblast growth factor (FGF) signaling (Gadea et al., 2008;
Kang et al., 2014; Sirko et al., 2013; Zamanian et al., 2012). To
obtain a more comprehensive view on the key regulators of reac-
tive astrocyte proliferation, we set out to examine the pattern of
gene expression in reactive astrocytes at the peak of their prolifer-
ation following stab wound injury in comparison to nonprolifer-
ative astrocytes in the intact adult cerebral cortex GM.
As a subset of proliferating reactive astrocytes acquire
neural stem cell (NSC) potential after injury, monitored by
the ability to form multipotent, self-renewing neurospheres
(Buffo et al., 2008; Grande et al, 2013; Sirko et al., 2013),
this prompts the question how much of the gene expression
changes of reactive astrocytes may be shared with NSCs.
Only genomewide expression analysis comparing reactive
astrocytes, NSCs and nonreactive astrocytes allow determining
the degree of similarity between NSCs and reactive astrocytes
and the extent of injury-specific gene expression.
A small number of candidates shared by reactive astro-
cytes and endogenous NSCs have already been identified and
tested, including glial fibrillary acidic protein (GFAP), Nestin,
Musashi, DSD1-proteoglycan, and Tenascin-C (for review, see
G€otz et al., 2015; Robel et al., 2011; Sirko et al., 2009).
However, these proteins also appear in injury conditions with-
out reactive proliferation of astrocytes and/or neurosphere for-
mation (Kamphuis et al., 2012; Robel at al., 2011), thus
emphasizing the need for additional molecular insights.
Toward this aim, we compared genomewide expression of
astrocytes reacting to stab wound with astrocytes from the
intact adult GM, as well as an existing expression profile of
endogenous NSCs located in the adult SEZ (Beckervorder-
sandforth et al., 2010).
Materials and Methods
Animals
The experiments were performed with 2–3 months old C57BL/6J
mice (Charles River Laboratories; Sulzfeld, Germany) and the
transgenic lines in which enhanced green fluorescent protein
(eGFP) is driven by the aldehyde dehydrogenase 1 family member
L1 Tg(Aldh1l1-eGFP)OFC789Gsat (Heintz, 2004) or human
GFAP TgN(hGFAP-EGFP)GFEA (Nolte et al., 2001) and
Lgals12/2Lgals32/2 mice on C57BL/6J background (Colnot et al.,
1998). Animals were allocated to experimental groups regarding
their genotype and kept under standard conditions with access to
water and food ad libitum. Animal handling and experimental pro-
cedures were performed in accordance with German and European
Union guidelines and were approved by the State of upper Bavaria.
All efforts were made to minimize suffering and number of animals
used.
Surgical Procedures
Stab wound in the GM of the somatosensory cerebral cortex was
performed as previously described (Buffo et al., 2008). Briefly, ani-
mals were anaesthetized and, using a stereotactic apparatus, subjected
to 0.7 mm deep and 1–1.2-mm long stab wound. Proliferating cells
were labeled with 50-bromo-desoxyuridine (BrdU; Sigma Aldrich)
added to the drinking water (1 mg/mL water containing 1% sucrose)
for 5 days or by single intraperitoneal BrdU injection (10 mg/100 g
body weight) 2 h prior analysis. Operated animals were divided into
two groups: one group sacrificed at 5 day past injury (dpi) and one
group composed of animals sacrificed at increasing times after injury
(1, 3, and 7 dpi).
Tissue Dissociation and Purification of Cells Using
Fluorescence-Activated Cell Sorting
Cortical cells from a tissue volume (1 0.35 cm) punched from the
lesioned somatosensory GM of GFAP-eGFP mice at 5 dpi or the
corresponding region of noninjured Aldh1L1-eGFP mice were disso-
ciated as described previously (Buffo et al., 2008), sorted by a
fluorescence-activated cell sorting [FACS] Aria (BD) and processed
for ribonucleic acid (RNA) isolation, as described by Beckervorder-
sandforth et al. (2010) and in Supp. Info. M1.
Analysis of the Microarray Data
Analysis of differential gene expression was performed on normalized
log2-transformed intensities using Bioconductor packages imple-
mented in CARMAweb (Rainer et al., 2006), including limma t-test
and Benjamin–Hochberg multiple testing corrections with false dis-
covery rate (FDR) <10%. To generate the injury-induced signature
of reactive astrocytes, only genes with significant (FDR< 10%) regu-
lation were selected. For direct comparison of average expression in
adult NSCs, the datasets from Beckervordersandforth et al. (2010)
were reprocessed along with samples in this study. Genes upregulated
in both the aNSCs and reactive astrocytes were defined by limma t-
test P-value< 0.01 and fold change >23 in both comparisons ver-
sus nonreactive astrocytes. The downregulated gene set (215 probe
sets) in aNSCs and reactive astrocytes was defined similarly
(FDR< 10%, fold change >23 down). Regulated gene sets were
analyzed for statistically enriched biological processes (Gene Ontol-
ogy; GO terms) and signal transduction pathways using the
Genomatix Pathway System (GePS). Microarray data was submitted
to GEO (GSE18765 and GSE66370).
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Immunohistochemistry and In Situ Hybridization
After transcardial perfusion with phosphate buffered saline (PBS) fol-
lowed by 4% paraformaldehyde (PFA) in PBS, brains were removed,
postfixed in 4% PFA for 4 h at 48C and processed for immunostain-
ings or in situ hybridization (ISH), as described previously (Brill
et al., 2009; Sirko et al. 2013). Nuclei were visualized with 40,60-dia-
midino-2-phenylindole (DAPI; 0.1 mg/mL; Sigma Aldrich). For anti-
bodies and probes see Supp. Info. M2,3.
Neurosphere and Reactive Gliosis Cultures
Neurospheres were prepared from cells of the injured GM of C57BL/6J
(n5 6) and Lgals12/2Lgals32/2 (n5 6) mice at 5 dpi as described in
Sirko et al. (2013) (see also Supp. Info. M4). For some experiments, we
used 50 mg/mL of human recombinant Galectin 1 (Gal-1) and/or
Galectin 3 (Gal-3), which were purified from Escherichia coli cultures
and added at the beginning of the experiment and after 3 day in vitro
(div). Galectin activity was measured prior by the hemagglutination
assay (Supp. Info. M3). For the adherent cultures, cells from the
lesioned area were dissociated and cultured in 1mL medium (DMEM/
F-12, 1% B27 Supplement, 1% penicillin-streptomycin, 1 mL of 45%-
Glucose, and 10% FBS [both Life Technologies]) on poly-D-lysine
coated coverslips. At 2 div, the culture medium was replaced with 1 mL
of freshly prepared medium containing 50-ethynyl-20-deoxyuridine
(EdU) (10 mM/mL; Life Technologies) and with or without Galectins
(50 mg/mL). At 6 div, cells were fixed and stained (Supp. Info. M5).
Statistical Analysis
Confocal laser scanning (Zeiss LSM5; Zeiss LSM710) microscope was
used to quantify immunopositive cells in sections or cell culture. For
each of the quantifications, at least three animals or experimental culture
batches were examined. All quantifications of immunohistochemistry
are based on analysis of at least five sections per animal. The incidence
of immunopositive cells in cell culture was expressed either relative to
the total cell number (500–1,000 DAPI-stained nuclei per coverslip) or
the number of co-stained cells. Statistical analyses of data were per-
formed using the GraphPrism 5.0 software. Data were tested for the nor-
mal distribution using the Kolmogorov–Smirnov test, and significance
between means from two experimental groups was analyzed using of
two-tailed unpaired Student’s t-test and between multiple groups by
one-way analysis of variance (ANOVA) analysis. All values were plotted
as mean6 standard error of the mean (SEM), unless otherwise stated.
Significance indicated as *(P< 0.05), **(P< 0.01), ***(P< 0.001).
Results
Labeling Parenchymal Astrocytes in the Intact and
Injured GM of the Adult Cerebral Cortex
NSCs have been previously isolated by FACS using two criteria,
their GFAP expression using hGFAP-eGFP mice (Nolte et al.,
2001) and their epithelial properties with Prominin1 located
on their apical surface (Beckervordersandforth et al., 2010;
Pinto et al., 2008). When examining the expression of eGFP
driven by the hGFAP promoter in the normal cerebral cortex
GM (Fig. 1A), only a minority of GM astrocytes at subpial
positions (Nolte et al., 2001) were labeled by GFP or GFAP
(Fig. 1A0, A00), in contrast to the widespread GFAP labeling in
the SEZ at the lateral ventricle (lower row in Fig. 1C). In our
search for a mouse line labeling more astrocytes in the GM, we
examined Aldh1L1-eGFP mice (Fig. 1C, D). Aldh1L1 is
expressed in astrocytes in young rodent tissue (Cahoy et al.,
2008), but has been suggested to decrease during ageing (Yang
et al., 2011). In the 2–3-months old Aldh1L1-eGFP mice, we
found virtually all astrocytes labeled by S100b (Fig. 1C) to be
GFP1, and no GFP signal was observed in NeuN1 neurons,
NG21 glia, or Iba11 microglia (data not shown). Thus, the
Aldh1L1-eGFP animals were deemed best suited for isolating
astrocytes from the uninjured cerebral cortex GM.
After stab wound, many but not all GM astrocytes upreg-
ulate GFAP (Fig. 1B, D; see also Bardehle et al., 2013; Buffo
et al., 2008; Sirko et al., 2013). Accordingly, only about 60%
of Aldh1L1-GFP1 cells were GFAP1 within 500 mm of the
lesion (Fig. 1D). Thus, GFP1 cells in this mouse line comprise
reactive (GFAP1) and nonreactive (GFAP2) astrocytes (Fig.
1D0). Conversely, eGFP driven by the hGFAP promoter labeled
virtually all GFAP1 astrocytes that were also hypertrophic in
the injured GM (Fig. 1B). The hGFAP-GFP1 astrocytes also
comprised almost all cycling (Ki671 or BrdU1 astrocytes (Fig.
1B0, F). The increase in hGFAP-GFP1/GFAP1 astrocytes
over the first days after injury (Fig. 1E) occurred in parallel
with the increase of reactive astrocytes proliferation, which
reached the peak at 5 dpi (Fig. 1F, G). Thus, expression of GFP
in the injured GM of hGFAP-eGFP mice is specifically
restricted to reactive astrocytes and faithfully reflects the pro-
gression of astrogliosis, including the proliferative astrocyte
reaction. Besides being best suited for monitoring reactive
astrocytes, the hGFAP-GFP line was also used to isolate SEZ
NSCs (Beckervordersandforth et al., 2010) and hence allows
for best comparison between reactive astrocytes and NSCs.
Selective Enrichment of Reactive and Nonreactive
Cortical GM Astrocytes via FACS
To isolate GFP1 astrocytes (Fig. 2A), we prepared single cell
suspensions from biopsy punches of the intact somatosensory
GM of 2–3-months old Aldh1L1-eGFP mice. GFP1 cells
were sorted by gating out cell debris, duplets, and non- or
autofluorescent cells by setting the gate for GFP in compari-
son to nonfluorescent cells prepared from wild-type (wt) mice
(Fig. 2B). Cells plated before and after sorting documented
the high enrichment of sorted cells from less than 20% in the
starting population to 95% GFP1 cells after sorting (Fig.
2C, D). The astroglial identity of the GFP1 sorted cells was
confirmed by co-staining for S100b (91% of GFP1 cells iso-
lated from Aldh1L1-eGFP mice were S100b1, Supp. Info.
Fig. 1A). For sorting of reactive astrocytes (Fig. 2A), we iso-
lated GFP1 cells from hGFAP-GFP mice at 5 dpi, the peak
of astrocyte proliferation. This resulted in a similar
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FIGURE 1: Characterization of astrocytes in the intact and injured somatosensory cortex. (A) Fluorescence micrographs of GFP immuno-
reactivity in the intact somatosensory cortex of hGFAP-eGFP mice at postnatal day (P65). Note that GFP is limited to few subpial astro-
cytes in the cortical layer I (LI) or parenchymal astrocytes in the vicinity of blood vessels (BV) in the intact cerebral cortex (Ctx). (B) After
stab wound injury of hGFAP-eGFP mice of the same age, GFP was found in virtually all GFAP1 reactive astrocytes including proliferating
(Ki671) reactive astrocytes (white arrowheads in B0). (C) Fluorescence micrographs depict representative confocal images of GFP immu-
nostaining in the intact cerebral cortex (upper panel) of Aldh1L1-eGFP transgenic mice. Double-immunopositive cells for the calcium
binding protein S100b in the intact gray matter (GM) and GFAP in the intact corpus callosum (CC), striatum (Str) and subependymal layer
of lateral ventricle (LV) (lower panel). (D) Stab wound injury of Aldh1L1-eGFP somatosensory GM induces a broad expression of GFAP in
many (white arrowhead), but not all GM astrocytes (red arrowheads) at the injury site (D0). (E) Histogram depicting the number of the
hGFAP-GFP1 astrocytes in the penumbra of the injury increasing significantly over the first 7 dpi. (F) Fluorescence micrograph shows
labeling for the DNA base analog BrdU (given 31 i.p. 2 h before immunohistological processing) in GFP1 and GFAP1 astrocytes 5 dpi
in hGFAP-eGFP mouse cerebral cortex GM. (G) Quantification of the number of such cells is shown in the histogram with a significant
increase within the first 5 dpi. All data are plotted as mean6SEM from n55 experiments. Significance between means was analyzed
using of one-way ANOVA test and indicated as *(P<0.05), **(P<0.01), ***(P<0.001). Scale bars: (A–D) 100 lm, (A0) 50 lm, (B0, D0) 25
lm, (A00, F) 10 lm.
enrichment (93% of sorted cells were GFP1, Fig. 2C, D)
with 97% of the sorted GFP1 cells GFAP-immunoreactive
(Supp. Info. Fig. 1A). Thus, this reproducible sorting proto-
col allowed isolation of nearly pure astrocytes from intact and
injured adult cerebral cortex GM.
Injury-Induced Changes of Gene Expression in the
Cerebral Cortex GM Astrocytes
RNA was extracted from the sorted astrocyte populations (see
also Supp. Info. M1), and amplified for hybridization on Affy-
metrix Mouse Genome 430 2.0 arrays. As expected, a large
number of common genes were found to be expressed in reac-
tive and nonreactive astrocytes (Fig. 3A, B; see also Beckervor-
dersandforth et al., 2010; Cahoy et al., 2008; Zamanian et al.,
2012; Zhang et al., 2014). Conversely, genes specific for neu-
rons, microglia, or oligodendroglia were consistently very low,
confirming the selective sorting of astrocytes (Fig. 3B; see also
Cahoy et al., 2008; Zhang et al., 2014). Notably, reactive astro-
cytes showed significantly lower expression of most astrocyte-
specific genes (selected as astrocyte-specific from Cahoy et al.
FIGURE 2: Purification of astrocytes from the intact and injured somatosensory cortex GM using fluorescence-activated cell sorting
(FACS). (A) Schematic representation of experimental design used for the tissue dissection and purification of astrocytes from intact or
stab wound-injured cerebral cortex GM. (B) FACS plots show the sorting gates that were used in hierarchical way for isolation of astro-
cytes, based on cell size (forward scatter, FSC) and granularity (side scatter, SSC) (upper layer), discrimination of doublets (FSC-area vs.
FSC-width; middle layer) and positive selection for GFP1 cells (lower layer). (C) Bar graphs depict proportions of GFP1 astrocytes
before (unsorted) and after FACS sorting (GFP-sorted), indicating high efficiency of the sorting procedure. (D) Purity of sorting cell popu-
lations was confirmed by immunostaining of cells before (unsorted) and after FACS sorting (sorted). All data are plotted as mean6SEM
from n5 experiments. Significance between means from two experimental groups was analyzed using of two-tailed unpaired Student’s
t-test and indicated as *(P<0.05), **(P<0.01), ***(P<0.001). Scale bars: (D) 75 lm
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2008, Zhang et al. 2014), except for Aldh1l1 and GFAP (Fig.
3B). However, this was not accompanied by upregulation of
neuronal or other glia-specific genes (Fig. 3B), suggesting that
astrocytes do not acquire other lineage characteristics, while
they apparently reduce astrocyte-specific gene expression, con-
sistent with partial dedifferentiation.
Statistical analysis revealed 916 significantly regulated
transcripts between astrocytes isolated from the injured versus
FIGURE 3: Genomewide expression analysis of astrocytes from the intact or injured cerebral cortex GM. (A) Scatter plot of whole
genome expression profile in nonreactive (Aldh1L1-eGFP) and reactive (hGFAP-eGFP) astrocytes depicted at normalized expression lev-
els of all probe sets from the Affymetrix GeneChip Mouse Genome 430 2.0 arrays presented on log2 scale. Black lines indicated bounda-
ries of twofold difference in gene expression levels. (B) Both isolated astrocyte populations express high level of astroglia-specific
genes. The y-axis represents normalized expression of probe sets for cell-type-specific markers from the array. (C) Heat map showing
the top 20 genes that significantly differ between astrocytes from intact or injured cerebral cortex (the normalized values are plotted on
a log2 color scale, and color indicates up- (red) and downregulation (blue), as compared with the mean and linear fold changes (reactive
vs. nonreactive astrocytes) are provided). (D) Transcript levels of several genes were confirmed by quantitative RT-PCR and are shown in
comparison to GeneChip expression levels. Data are plotted as mean6SEM from independent biological/technical replicates. Signifi-
cance between experimental groups was analyzed using of two-tailed unpaired Student’s t-test and indicated as *(P<0.05), **( P<0.01),
***( P<0.001). (E) The top five genes significantly enriched in both reactive astrocyte and adult neural stem cells (aNSC SEZ; see Becker-
vordersandforth et al., 2010) in comparison to the non-reactive astrocytes are shown as a heat map as described above (for complete
list, see Table 2). (F) Bars show 10 selected major GO classes associated with genes significantly enriched in both reactive astrocytes
and aNSCs. (G, H) Immunofluorescence for cyclin D1 (in red) in frontal sections of intact (G) or injured (5 dpi, H) cerebral cortex confirm
the injury-induced expression of cyclin D1 (Ccnd1) in reactive astrocytes (white arrowheads), while astrocytes in the intact GM do not
express cyclin D1 (yellow arrowheads). The cell nuclei were counterstained with DAPI. Scale bars: (G, H) 100 lm.
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TABLE 1: Genes regulated in cortical astrocytes in response to stab wound injury
Top 50 genes upregulated in reactive astrocytes Top 50 genes downregulated in reactive astrocytes
Probe set ID Gene symbol Fold induction Probe set ID Gene symbol Fold induction
1449254_at Spp1 288.25 1443745_s_at Dmp1 233.61
1436996_x_at Lyz1 56.94 1442340_x_at Cyr61 228.61
1423547_at Lyz2 48.88 1449335_at Timp3 228.46
1426808_at Lgals3 42.71 1447517_at Skiv2l2 227.99
1454268_a_at Cyba 37.11 1430966_at Cml3 225.64
1423754_at Ifitm3 28.54 1447150_at Mycbp2 221.53
1417104_at Emp3 25.58 1433830_at Hnrnpa2b1 221.47
1434437_x_at Rrm2 25.03 1453514_at Gpm6b 220.53
1420394_s_at Gp49a 22.66 1457410_at Arhgap5 218.32
1452352_at Ctla2b 21.56 1440037_at Pbx1 217.65
1420804_s_at Clec4d 18.76 1440770_at Bcl2 216.03
1449164_at Cd68 18.52 1452378_at Malat1 215.61
1426278_at Ifi27l2a 17.70 1439675_at Ppara 215.43
1456292_a_at Vim 17.19 1433413_at Nrxn1 212.90
1453773_at Rnf220 16.46 1458469_at Cblb 212.80
1417268_at Cd14 15.42 1439556_at Ncam1 212.77
1425140_at Lactb2 14.42 1424393_s_at Adhfe1 212.37
1449401_at C1qc 13.98 1454904_at Mtm1 212.33
1417381_at C1qa 13.32 1441185_at Msi2 211.65
1417876_at Fcgr1 12.99 1438103_at Pcdhgc4 211.49
1417063_at C1qb 12.91 1440789_at Neo1 210.98
1455660_at Csf2rb 12.42 1457445_at Trps1 210.84
1417346_at Pycard 12.40 1438089_a_at Bclaf1 210.21
1460351_at S100a11 11.85 1455799_at Rorb 210.04
1460218_at Cd52 11.67 1456923_at Trpm3 210.00
1434447_at Met 11.44 1421180_at Lix1 29.53
1460330_at Anxa3 11.01 1417408_at F3 29.50
1419004_s_at Bcl2a1a 10.77 1427143_at Kdm5b 29.46
1448982_at Klk6 9.94 1429515_at Ubr2 29.39
1451335_at Plac8 9.90 1433757_a_at Nisch 29.29
1450826_a_at Saa3 9.55 1439940_at Slc1a2 29.23
1451931_x_at H22L 9.17 1419748_at Abcd2 29.06
1424754_at Ms4a7 8.99 1425362_at Agfg2 28.89
1419482_at C3ar1 8.63 1427293_a_at Auts2 28.82
1440142_s_at Gfap 8.61 1422955_at Syt17 28.73
1438948_x_at Tspo 8.54 1421093_at Slc7a10 28.64
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intact GM (599 downregulated and 317 upregulated in
reactive astrocytes; top 50 up- or downregulated genes in
Table 1). Consistent with previous microarray analyses (Beck-
ervordersandforth et al., 2010; Johansson et al., 2013; Nin-
kovic et al., 2013; Pinto et al., 2008, 2009; Stahl et al.,
2013; Walcher et al., 2013), quantitative reverse transcription
polymerase chain reaction (qRT-PCR) confirmed the changes
observed in the microarray (Fig. 3D), including the strongly
upregulated genes Lgals1 (lectin, galactoside-binding, soluble,
1) and Lgals3 (lectin, galactoside-binding, soluble, 3) (403
and 103, respectively).
To further identify genes regulated in reactive astrocytes
with relevance for proliferation or regulation of NSC hall-
marks, we then compared the genomewide expression pattern
of reactive and nonreactive astrocytes with the one of NSCs
from the SEZ of healthy and age-matched hGFAP-eGFP
mice, which were previously analyzed in our lab under identi-
cal conditions (Beckervordersandforth et al., 2010). Thereby,
we focused on genes (147 transcripts) expressed at signifi-
cantly higher levels in both reactive astrocytes and NSCs
compared with nonreactive astrocytes from the intact adult
GM (Fig. 3E, Supp. Info. Table 1). Remarkably, beside the
proliferation gene ribonucleotide reductase M2 (Rrm2), Lgals3
was the gene with the second highest upregulation (653) in
both reactive astrocytes and adult NSCs (Fig. 3E). As also
Lgals1 is significantly upregulated in reactive astrocytes and
both have been implicated in regulating adult NSCs (Becker-
vordersandforth et al., 2010; Di Lella et al., 2011; Kajitani
et al., 2009; Sakaguchi et al., 2006; Yan et al., 2009), this
prompted us to focus on the role of Lgals1 and Lgals3 in the
injured cerebral cortex.
Expression of Galectins 1 and 3 Identifies a Subset
of Reactive Astrocytes in the Injured Cerebral
Cortex GM
By qRT-PCR and ISH, Lgals1 and Lgals3 expression was very
low in the intact cerebral cortex while much higher in the
NSC niche, the SEZ (Fig. 4A, E). At 5 days after stab wound
injury, however, expression was also much higher in the GM
surrounding the injury site (Fig. 4D, E). Notably, Lgals
mRNA co-localized with GFAP, supporting its expression in
reactive astrocytes (Fig. 4F). Immunohistochemistry also
revealed low numbers of Galectin 1 (Gal-1) or Galectin 3
(Gal-3) immunopositive cells in the intact cortex, most of
which were neurons and not astrocytes (Fig. 4B and data not
shown; note that antibody specificity was assessed using brain
TABLE 1: Continued
Top 50 genes upregulated in reactive astrocytes Top 50 genes downregulated in reactive astrocytes
Probe set ID Gene symbol Fold induction Probe set ID Gene symbol Fold induction
1457644_s_at Cxcl1 8.44 1460567_at Rfx7 28.62
1435290_x_at H22Aa 8.37 1442223_at Enah 28.53
1415828_a_at Serp1 8.32 1454070_a_at Ddhd1 28.41
1421578_at Ccl4 8.20 1417962_s_at Ghr 28.31
1424164_at Mrpl50 8.10 1438751_at Slc30a10 28.24
1452428_a_at B2m 8.07 1423594_a_at Ednrb 28.18
1449227_at Ch25h 7.68 1444468_at Paqr8 28.09
1449773_s_at Gadd45b 7.52 1451257_at Acsl6 28.02
1419091_a_at Anxa2 7.45 1439108_at Mll5 27.96
1418204_s_at Aif1 7.43 1439582_at Macf1 27.95
1416326_at Crip1 7.21 1429427_s_at Tcf7l2 27.92
1427736_a_at Ccrl2 7.18 1429461_at Ints2 27.76
1419573_a_at Lgals1 7.01 1416130_at Prnp 27.75
1418340_at Fcer1g 7.00 1418024_at Naa15 27.68
Shown are top 50 genes selected by stringent filters for statistical significance (FDR< 10%), fold change> 23, and an average expression
level >50 in at least one cell population. Genes are sorted according to fold induction/reduction in reactive relative to nonreactive
astrocytes.
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FIGURE 4: Injury-induced expression of Galectins 1 and 3 in parenchymal astrocytes of the adult cortical GM. (A) In the intact forebrain,
expression of Galectin-1 (Gal-1) (upper panels) or Galectin-3 (Gal-3) (lower panels) is restricted to the adult SEZ at the lateral ventricle
(LV), where these lectins labeled also proliferating GFAP1 cells shown in the inserts to the right. (B) In the intact cerebral cortex, Gal-3-
immunostaining is virtually not detectable, while Gal-1 is occasionally associated with Aldh1L1-eGFP-negative neurons (white arrow-
heads). (C) Only few GFAP-positive astrocytes were Gal-1- and/or Gal-3-immunoreactive in the intact cerebral cortex and these were
located in the perivascular surroundings (BV, blood vessels). (D) In the stab wound-injured cerebral cortex, many hGFAP-eGFP/GFAP-
positive astrocytes are Gal-11 or Gal-31 (white arrowheads) at 5 dpi. (E, F) Combined ISH and immunohistochemistry on frontal sections
from intact (E) or injured (right panels) forebrains using an anti-GFAP antibody and RNA probes for Lgals1 and Lgals3 transcripts show
increased Lgals1/3 expression after injury (F) and co-localization with GFAP (panels at higher magnification in F). The cell nuclei were
counterstained with DAPI. Scale bars: (B, D, E, F) 100 lm, (A, C) 50 lm.
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sections of Lgals12/2Lgals32/2 animals, see Supp. Info. Fig.
2). Conversely, many Gal-11 or Gal-31 cells were detected
in the cerebral cortex GM after stab wound injury. These
were hGFAP-GFP1 and/or GFAP1 reactive astrocytes (Fig.
4D). We noted that immunostainings for both lectins corre-
late well with the perimeter of GFAP-immunoreactivity in
the injured parenchyma at 5 dpi, and appeared more intense
within the lesion core or in the close vicinity to the wound
site (Fig. 5A–C). At this time point, GFAP1 reactive astro-
cytes comprised only 23% of all Gal-11 and 42% of all Gal-
31 cells around the lesion (Fig. 5B, C) with the remainder
of Gal-11/Gal-31 cells identified as Iba11 microglia or
NG21 glia (data not shown), consistent with previous data
(Bischoff et al., 2012; Liu et al., 1995; Qu et al., 2011;
Walther et al., 2000). Importantly, however, both Gal-1 and
Gal-3 labeled only a subset of reactive astrocytes (16 and
22%, respectively; Fig. 5E), consistent with the concept of
astrocyte heterogeneity after injury (Dimou and G€otz, 2014).
Strikingly, virtually all Ki671 reactive astrocytes were Gal-
31, while only half of the mitotic astrocytes were positive for
Gal-1 (Fig. 5D, F). Thus, especially Gal-3 is a novel marker
for cycling reactive astrocytes in the murine cerebral cortex
GM.
Lack of Lgals1/Lgals3 Results in Reduced GFAP
Expression and Proliferation of Astrocytes in the
Injured Cerebral Cortex GM
The prominent and highly specific upregulation of both lec-
tins in astrocyte subsets after injury prompts the question of
their functional role in this context. As Gal-1 and Gal-3 are
also secreted and can hence be provided by several cell types
in the cerebral cortex (e.g., neurons, microglia, and NG2 glia,
see above), we took advantage of the double knockout mice
Lgals12/2Lgals32/2 (Colnot et al., 1998) that lack both
galectins in all cells. After stab wound injury, we first noted
that the region covered by GFAP1 cells was smaller (Fig.
6A) and the number of GFAP1 astrocytes was reduced in
the Lgals12/2Lgals32/2 cerebral cortex compared with control
littermates (Fig. 6B). This effect occurred also at the tran-
scriptional level, as shown by qRT-PCR of mRNA from
injured GM of the cerebral cortex from wt or mutant mice
(Fig. 6B). As the number of astrocytes (S100b1) in the non-
injured as well as in injured GM was well comparable
between Lgals12/2 Lgals32/2 and wt mice (Supp. Info. Fig.
3A, B), this reduction is specific to the injury condition and
seems to affect GFAP expression levels rather than astrocyte
numbers. Indeed, when S100b1 astrocytes were double-
stained for GFAP, we noted a profound reduction in the
GFAP1 proportion in the injured Lgals12/2Lgals32/2 GM
(55%) compared with wt GM (90%; Supp. Info. Fig. 3B).
Note that cells were counted here within 300 mm of the
lesion site, where we find a higher proportion of GFAP1
astrocytes than in the larger area of 500 mm as quantified
above using the Aldh1L1-eGFP mice. Thus, both GFAP
and Gal-1 and Gal-3 are highest upregulated close to the
injury site (Fig. 5B), and fewer astrocytes become GFAP-
immunoreactive in the injured Lgals12/2Lgals32/2 GM.
As we had also seen a close connection between the
Gal-1/-31 subset of reactive astrocytes and the cycling reac-
tive astrocytes, we labeled cells in the cell cycle by immuno-
staining for Ki67. Indeed, double1 astrocytes (Ki671/
GFAP1) were significantly reduced to less than half in the
mutant mice (Fig. 6A, C). However, their preferential posi-
tion close to the blood vessels, as described previously (Bar-
dehle et al., 2013), was not altered in the absence of Gal-1
and Gal-3 (82.86 8.2% in wt and 88.66 9.3% in
Lgals12/2Lgals32/2) (Supp. Info. Fig. 3C).
Notably, also other glial cells were less often Ki671 and
the total number of Ki671 cells was significantly reduced to
less than half in the injured Lgals12/2Lgals32/2 GM (Fig.
6C). To examine whether reduced proliferation was restricted
to 5 dpi or also occurred throughout the entire time after the
injury, BrdU was continuously supplied after injury (Fig. 6D,
E). This revealed an even larger decrease in cells entering S-
phase, with less than 20% of BrdU-labeled reactive astrocytes
in the Lgals12/2Lgals32/2 compared with control cerebral
cortex injured GM (Fig. 6D, F). While microglia prolifera-
tion was also reduced, it was least affected compared with
astrocytes and NG2 glia (Fig. 6F). Taken together, these data
show that macroglial cells are most deficient in eliciting pro-
liferation after stab wound injury in the absence of Gal-1 and
Gal-3.
A further measure of astrocyte reaction correlated so far
to their proliferative reaction in vivo (Sirko et al., 2013) is
the acquisition of neurosphere-forming potential. As Gal-1
and Gal-3 were also high in adult SEZ NSCs, we would pre-
dict that in the absence of these proteins, the neurosphere-
forming capacity of astrocytes reacting to stab wound injury
should be reduced. As expected, the number of primary neu-
rospheres emerging from Lgals12/2Lgals32/2 cells dissociated
at 5 dpi was significantly diminished to less than half of the
control (Fig. 6H). This indicated that the number of cells
with neurosphere-forming potential is reduced in the cerebral
cortex GM lacking both Gal-1 and Gal-3. To determine
whether these lectins also play a role in the neurosphere self-
renewal spheres were passaged to determine the number of
secondary neurospheres emerging from the same number of
plated cells. As also the number of secondary neurospheres
was reduced (Fig. 6H), this indicates that either Gal-1 and/or
Gal-3 are also implicated in regulating self-renewal of neuro-
sphere cells in vitro. The remaining neurospheres, however,
were still multipotent even in the absence of Gal-1 or Gal-3
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FIGURE 5: Galectin-1/-3 labels subsets of reactive astrocytes in the injured cortical GM. (A, B) Fluorescence micrographs depicting the
stainings indicated on the left side of the panels show localization of Gal-1 and Gal-3 immunoreactivity in many cells, including a subset
of reactive astrocytes (GFAP-co-labelling in A, B). (C) Histogram depicting the number of Gal-11 and Gal-31 cells or astrocytes at differ-
ent distance to the injury site as indicated in B. Data are plotted as mean6SEM from n5 experiments. (D) Co-localization with Ki67
and GFAP (white arrowheads) reveals that the subset of astrocytes double-positive for Gal-1 or Gal-3 (for quantification, see pie chart in
E) are all (Gal-3; arrowheads) or most (Gal-1; arrowheads) Ki671 (for quantification in histogram see F). Data are plotted as mean6SEM
from n55 experiments. Significance was analyzed using of two-tailed unpaired Student’s t-test and indicated as *(P<0.05), **(P<0.01),
***(P<0.001). The cell nuclei were counterstained with DAPI. Scale bars: (B) 100 lm, (D) 75 lm, (B0–B00 0) 50 lm, (A) 25 lm.
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to the same extent as in controls (data not shown). Thus,
Gal-1/Gal-3 signaling affects GFAP activation and prolifera-
tion in reactive astrocytes as well as their stem cell potential.
Distinct Effects of Extrinsic Galectins 1 and 3 on
Reactive Glia Proliferation
Next we aimed to determine whether the observed defects in
astrocyte proliferation and neurosphere formation could be
rescued by acute supply with either Gal-1 or Gal-3 to dissect
which of these lectins may be responsible for the observed
effects. To do so, we examined reactive glia in adherent cul-
tures of cells isolated from the injured cerebral cortex GM of
either wt or Lgals12/2Lgals32/2 animals. In line with our in
vivo observations, the number of GFAP1 cells obtained at 3
or 5 dpi from Lgals12/2Lgals32/2 was reduced at 6 div (Fig.
7A, B). To monitor the proliferation of Lgals12/2Lgals32/2
glial cells, EdU was supplied to the culture medium at 2 div
and the cells incorporating EdU during S-phase were exam-
ined 4 days later. While more than 65% of wt cells had
incorporated EdU, only 25% of Lgals12/2Lgals32/2 cells did
so (Fig. 7A, C), confirming the decline in reactive glia prolif-
eration also in vitro.
We then added Gal-1 or Gal-3 (their activity was moni-
tored in parallel in a bioassay, see Supp. Info. M6) first to
cultures at 2 div from wt injured cerebral cortex GM and
observed a strong difference between the effects of Gal-1 and
Gal-3 addition. Gal-1 addition strongly reduced the total
pool of proliferating EdU1 cells from about 70 to 5% in
Gal-1-treated cultures (Fig. 7E). This effect was much weaker
for Gal-3 addition reducing EdU1 cells only by about half
(40%, Fig. 7E). In this regard, it is interesting to note that
the majority of proliferating cells in these cultures are micro-
glia (93.56 2.4% and 76.66 2.4% of EdU1 cells are Iba11
in wt and Lgals12/2Lgals32/2, respectively), and Gal-1 has
been previously shown to inhibit microglia activation (Bis-
choff et al., 2012; Starossom et al., 2012). Thus the reduced
number of cells in the reactive glia cultures upon Gal-1 addi-
tion is likely due to reduced microglia activation and prolifer-
ation. In addition, however, Gal-1 has been shown to elicit
cell death via integrin ligands (see Discussion section), such
that both cell death and reduced proliferation may lead to the
rather cell-depleted cultures upon Gal-1 treatment.
Next, we added Gal-1 and Gal-3 to the
Lgals12/2Lgals32/2 cells. Remarkably, addition of Gal-3
alone was sufficient to rescue the proliferation of Lgals12/
2Lgals32/2 cells (Fig. 7D, E), including astrocytes, to a level
close to untreated cultures of wt cells (Fig. 7F). Gal-3 also
significantly augmented the number of GFAP1 astrocytes, as
well as their proliferation, even beyond wt levels (Fig. 7F).
Notably, also in the Lgals12/2Lgals32/2 cell cultures, Gal-1
addition led to reduced cell numbers (Fig. 7D), but neverthe-
less increased proliferation of remaining Lgals12/2Lgals32/2
astrocytes (Fig. 7F). Taken together, these results indicate that
both lectins positively regulate proliferation of reactive
Lgals12/2Lgals32/2 astrocytes.
Galectin 3, But Not Galectin 1 Increases
Neurosphere Formation from Reactive Glia
Next, we examined whether Gal-1 and Gal-3 would affect the
NSC potential of reactive glia and rescue the severely reduced
neurosphere formation of Lgals12/2Lgals32/2 cells obtained
from the injured cerebral cortex GM. Gal-3, but not Gal-1
was found to significantly increase the number of neuro-
spheres, both from wt as well as Lgals12/2Lgals32/2 cells,
although the rescue was incomplete in the latter case (Fig.
7G). By contrast, Gal-1 addition rather inhibited the number
of neurospheres formed in wt cells, and could not improve
this low level of neurosphere formation in cultures obtained
from Lgals12/2Lgals32/2-injured cortex (Fig. 7G). These
findings thus reveal a selective effect of Gal-3 in promoting
neurosphere formation from reactive astrocytes. These find-
ings support the notion that elevated Gal-3 expression in the
FIGURE 6: Reduced number and proliferation of reactive astrocytes in the stab wound-injured cortical GM of Lgals12/2Lgals32/2 mice.
(A) Representative overview images shown distribution of proliferating reactive astrocytes (GFAP1/Ki671, arrowheads) in the penumbra
of the stab wound injury in the cerebral cortex of wild type (wt) and Lgals12/2Lgals32/2 mice. The boxed regions are shown at higher
magnification. (B) Quantification of the number of GFAP1 astrocytes (left histogram) and quantitative RT-PCR analysis of GFAP mRNA
(right histogram) showed significant reduction in the number of GFAP1 cells and GFAP mRNA levels in the cerebral cortex GM at 5
days after stab wound injury in Lgals12/2Lgals32/2 mice compared with wt. (C) Quantification of cells (white bars) and astrocytes (red
bars) proliferating (Ki671) at 5 dpi revealed a significant reduction of both in Lgals12/2Lgals32/2 compared with wt mice. (D) Quantifica-
tion of cells (left bars) or astrocytes (GFAP/BrdU, right bars) proliferating at any time after stab wound injury labeled by BrdU given dur-
ing these 5 dpi also revealed a significant decrease in proliferating cells and astrocytes (to less than 20% of the control) at the injury
site of Lgals12/2Lgals32/2 compared with wt cerebral cortex GM. (E) Micrograph showing reduced proliferative activity of microglial
cells (BrdU1/Iba1) after stab wound injury in Lgals12/2Lgals32/2 compared with wt cerebral cortex GM. (F) Pie chart depicting the com-
position of all cells proliferating within 5 dpi labeled by BrdU in wt (left) and Lgals12/2Lgals32/2 (right) cerebral cortex GM. Note that
macroglial cells are affected most. (G, H) Neurosphere formation (micrographs in G) of cells isolated at 5 dpi from the GM surrounding
the injury site was significantly reduced for both primary (18) and secondary (28) neurospheres from Lgals12/2Lgals32/2 compared with
wt mice. Data are plotted as mean6SEM from n5 experiments. Significance between experimental groups was analyzed using of
two-tailed unpaired Student’s t-test and indicated as *(P<0.05), **(P<0.01), ***(P<0.001). The cell nuclei were counterstained with
DAPI. Scale bars: (A, E, G) 100 lm, (E0, E00) 50 lm.
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reactive cortical astrocytes is not only a predictor of their
reactive status and proliferative activity in vivo, but also corre-
lates with their NSC potential in vitro.
Discussion
Insights from Genomewide Expression Analysis
Here we described the first genomewide expression analysis of
astrocytes reacting to stab wound in the adult cerebral cortex
GM. Previous expression analyses had either focused on non-
invasive injury, such as amyloid plaque deposition (Orre
et al., 2014), or were performed with young postnatal (P30)
astrocytes pooled from white matter (WM) and GM of the
cerebral cortex, striatum and hippocampus after stroke or
lipopolysaccharide (LPS) treatment (Zamanian et al., 2012).
Our transcriptome data, therefore, provides relevant, as well
as novel information about similarities and differences in
astrocyte gene expression in the adult cerebral cortex GM fol-
lowing stab wound injury.
Interestingly, several of the top-regulated genes were also
regulated in young postnatal astrocytes upon other injury
condition (Zamanian et al., 2012), such as osteopontin
(SPP1). Indeed, SPP1 is also upregulated in various other
CNS region after injury, such as astrocytes and M€uller glia in
the retina (Chan et al., 2014; Plantman, 2012; Wahl et al.,
2013; Zamanian et al., 2012). Likewise Lgals3, Vim, p65/
RelA, GFAP, and Lgals1 have been observed at increased levels
after different brain injury conditions (Engelmann et al.,
2014; Qu et al. 2011; Robel et al., 2011; Yan et al., 2009;
Zamanian et al., 2012; Zhang et al., 1998).
When analyzing GO terms and pathways beyond single
regulated genes, the top-significant GO term is “metabolic
process” (Supp. Info. Fig. 1B). Astrocytes play key roles in
brain metabolism (Bouzier-Sore and Pellerin, 2013; Pellerin,
2008), and the switch from a resting to a reactive phenotype
can trigger a change in metabolic phenotype (Steele and Rob-
inson, 2012). Interestingly, we found that many genes whose
expression was significantly increased in both SEZ NSCs and
reactive astrocytes compared with nonreactive astrocytes are
also related to metabolic processes (Fig. 3F, Supp. Info. Table
2), demonstrating similarities in metabolic programs between
reactive astrocytes and NSCs different from the ones of nor-
mal parenchymal astrocytes. This is particularly intriguing, as
metabolic pathways have been shown to be key in regulating
fate decisions and changes (see, e.g., Maryanovich and Gross,
2013) and specific aspects of the lipid metabolism have been
identified as a key pathway regulating adult NSC activity
(Bracko et al., 2012; Codega et al., 2014; Knobloch et al.,
2013). Thus, the metabolic signatures shared between SEZ
NSCs and reactive astrocytes are likely involved in regulating
the transition of astrocytes to a more plastic progenitor/NSC-
like phenotype after injury.
Notably, consistent with recent observations that FGF
signaling counteracts the reactive state of astrocytes (Kang
et al., 2014), FGF signaling was the strongest downregulated
pathway, after injury. Ultimately, reduced FGF signaling in
astrocytes reduces formation of the GFAP1 scar, implying
that reduced expression of members of this signaling pathway
helps to limit gliotic scar formation. In contrast, nuclear fac-
tor kappa-light-chain-enhancer of activated B cells (NF-jB)
signaling pathways mediating response to inflammatory sig-
nals was the top upregulated GO term highlighting signifi-
cant gene expression changes in reactive astrocytes related to
immune or inflammatory signaling (Table 2, including inter-
leukin [IL] 1b, IL-6, and IL-10 pathways, tumor necrosis fac-
tor a [TNFa] and toll-like receptor (TLR); see also Falsig
et al., 2004; Hamby et al., 2012; Henn et al., 2011;
Zamanian et al., 2012; Zimmer et al., 2011). These are the
mediators released by reactive astrocytes modulating immune
FIGURE 7: In vitro addition of Galectin 3, but not Galectin 1 promotes adult reactive glia proliferation, neurosphere formation and res-
cues the Lgals12/2Lgals32/2 reactive glia phenotype. (A) Fluorescence micrographs of cells stained for EdU (added at 2 div) and GFAP
in adherent cultures derived at 3 dpi from the injured cerebral cortex GM of wt or Lgals12/2Lgals32/2 mice. Note the double-labeled
reactive astrocytes proliferating during the 4 days in culture after EdU addition (white arrowheads). The boxed regions are shown at
higher magnification. (B, C) Histograms depicting the percent of GFAP1 cells (B, percent of DAPI1 cells), proliferating (EdU1, white in
C) or proliferating GFAP1 cells (red in C) in the above cultures isolated at 3 or 5 dpi (as indicated on the x-axis) from wt and Lgals12/2
Lgals32/2 cerebral cortex GM. Note that approximately twice as many astrocytes are proliferating among wt cells compared with
Lgals12/2Lgals32/2 cells, indicating a cell autonomous effect. Data are plotted as mean6SEM from n55 experiments. (D–G) In vitro
addition of Gal-1 or Gal-3 as indicated in the fluorescence micrograph panels (D) or the histograms (E-G). For experiments shown in D-F,
Gal-1 (1Gal-1) or Gal-3 (1Gal-3) were added 13 and cells were fixed without further medium change 4 days later, stained for GFAP and
Iba1 in combination with EdU labeling, as shown in the micrograph in (D) and quantified as indicated in (E, F). Note the differential
effect of Gal-1 addition, which largely mediated cell death versus Gal-3 addition, which promoted proliferation of cells (E) and fully res-
cued the defective proliferation of Lgals12/2Lgals32/2 cells (E, F). (G) The total number of primary neurospheres generated from wt or
Lgals12/2Lgals32/2 reactive glia, plated in the growth factors-containing medium for 14 days with addition of Gal-1 or Gal-3. Note, that
the number of spheres obtained from the Gal-3-treated wt or Lgals12/2Lgals32/2 reactive glia was significantly increased in comparison
to control cultures (w/o). All data are plotted as mean6SEM from n55 experiments. Significance between experimental groups was
analyzed using of two-tailed unpaired Student’s t-test (in A, C, F) or one-way ANOVA test (in E, G) and indicated as *(P<0.05),
**(P<0.01), ***(P<0.001). The cell nuclei were counterstained with DAPI. Scale bars: (A) 100 lm, (D) 50 lm.
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cell invasion after injury (Burda and Sofroniew, 2014). Specif-
ically NF-jB signaling has been implicated in gene expression
events that impact on cell survival, differentiation, and prolif-
eration (Napetschnig and Wu, 2013; Oeckinghaus et al.,
2011). Interestingly, cyclin D1 (Ccnd1), a known NF-jB tar-
get (Guttridge et al., 1999; Hinz et al., 1999), is also signifi-
cantly upregulated in reactive astrocytes (Fig. 3E, F) and
might thus be one of the positive regulators of reactive astro-
cyte proliferation, integrating various damage and inflamma-
tory signals to instruct astrocyte proliferation.
Ccnd1 is also a target of Shh pathway (Kenney and
Rowitch, 2000) and the injury-induced activation of Shh sig-
naling promotes proliferation of reactive astrocytes (Sirko
et al., 2013). Notably, at 5 dpi, the peak of proliferation of
reactive astrocytes, we detected no significant upregulation of
the genes encoding for Patched, Smo, and Gli family pro-
teins, suggesting either that their upregulation may have taken
place prior to reaching the peak of proliferation, or these are
not regulated at the transcriptional level in this context. Inter-
estingly, Patched 1 regulates cell cycle progression by affecting
the subcellular localization of the M-phase promoting factor
that consists of two proteins: the kinase Cdk1 and the cyclin
B1 (Barnes et al., 2001; Doree and Hunt, 2002). Although
the level of Ptch1 expression in reactive astrocytes was not
significantly changed, it is possible that binding of extracellu-
lar Shh can disrupt interaction between Ptch1 and phospho-
rylated cyclin B1, thus allowing the complex to localize to the
nucleus where it stimulates the G2 to M-phase transition, as
has been shown for Shh-treated cells in vitro (Barnes et al.,
2001; Ruiz i Altaba et al., 2002). As transcriptional regulation
during G1-to-S transition is dependent on E2F transcription
factors family (for review, see Bertoli et al., 2013), it is rele-
vant to note that E2F2 and E2F8 were also strongly induced
in reactive astrocytes. Thus, proliferation of reactive astrocytes
is regulated at the transcriptional level by increasing the tran-
scription of several proproliferative components, while their
regulation by the Shh pathway is not reflected at the tran-
scriptome level at least at this time point.
Our analysis was performed at the peak of reactive
astrocyte proliferation and accordingly, we found that many
upregulated genes are involved in the generation of precursor
metabolites including RNA metabolism and cell cycle promo-
tion. However, only about 10–20% of astrocytes divide in
this injury model (Bardehle et al., 2013; Simon et al., 2011),
suggesting that only some may reach levels of expression suffi-
cient to complete the cell cycle. Indeed, some genes, for
example, Ccnd1 appear clearly in a subset of astrocytes (Fig.
3G, H and Supp. Info. Fig. 3D–F; Zamanian et al., 2012),
supporting the concept that our analysis allows detection of
genes expressed in the proliferative subset of reactive
astrocytes.
Subtypes of astrocytes also exist in regard to GFAP
expression as only a subset of Aldh1L1-GFP1 have GFAP
after stab wound injury. As our transcriptome analysis exam-
ined the GFAP1 cells using the hGFAP-eGFP mice, this
prompts the question to which extent altered gene expression
in our transcriptome would also be detectable in the GFAP-
negative astrocytes. To get a first idea on this we examined
five of the upregulated genes by co-immunostaining for
GFAP and GFP in Aldh1L1-eGFP mice (Supp. Info. Fig. 4;
Spp1, Gal-1, Gal-3, cyclin D1, and FGFR3). All of these
were typically restricted to the vicinity of the injury site and
to GFAP-immunopositive cells, but virtually not detectable in
GFAP-negative, Aldh1L1-GFP1 cells. Note that some of
these nonreactive astrocytes are rather close to the injury site.
Indeed, also live in vivo imaging of astrocytes after stab
wound injury revealed a subset of astrocytes, sometimes in
close vicinity to the injury site that showed no signs of reac-
tivity (no proliferation, polarization, or detectable hypertro-
phy; Bardehle et al., 2013), consistent with the concept of
reactive astrocyte heterogeneity with a subset showing little to
no reaction. To further scrutinize this concept of a subset of
nonreactive astrocytes, it will, however, be important to per-
form genomewide expression analysis by, for example, isolat-
ing the GFP1 and RFP1/GFP1 astrocytes from crosses of
Aldh1L1-eGFP and hGFAP-RFP mice.
For the GFAP1 reactive astrocytes analyzed here, it is
also important to note that not only proliferation genes are
upregulated, but also the GO term analysis also indicates sig-
nificant enrichment of genes involved in developmental proc-
esses and cell differentiation (Supp. Info. Fig. 1B, C and
Supp. Info. Table 3), indicating the more immature nature of
reactive astrocytes compared with astrocytes in the intact
brain. Notably, some neurogenic factors, such as Sox11 (sex-
determining region y-box, 11) (Mu et al., 2012; Ninkovic
et al. 2013) are upregulated in reactive astrocytes, but do not
reach the levels of the neurogenic priming observed in SEZ
NSCs (Beckervordersandforth et al., 2010; Bracko et al,
2012; G€otz et al., 2015). Consistent with some degree of cell
fate change, the gliogenic genes, Nfib (nuclear factor I/B) and
Sox9 are downregulated in reactive astrocytes compared with
astrocytes from the intact brain. Likewise some genes also
expressed in SEZ NSCs, such as Sox2, Musashi1 and its up-
stream regulator Rfx7 (regulatory factor, 37), are rather
downregulated in reactive astrocytes (Supp. Info. Table 2),
possibly counteracting the further dedifferentiation. Taken
together, genomewide expression analysis not only reveals a
significant number of genes expressed by endogenous adult
SEZ NSCs, which are upregulated by reactive astrocytes, but
also identifies genes involved in limiting their self-renewal
capacity in vivo and neurogenic progeny (see, e.g., Shimada
et al., 2012).
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TABLE 2: Gene expression pattern analysis of regulated signal transduction pathways
Signal transduction pathway
associations
P value Genes
Pathways upregulated in reactive astrocytes at 5 days after stab wound injury
NF kappa B 6,54 E 206 Cd14, Cd83, Aif1, Litaf, Nfkbia, Cebpb, Nfkbid, Cxcl1, Ier3,
Cd74, Bcl3, Il1b, Tnfrsf1b, Spp1, Nfkbib, Bcl2a1a, S100a4,
Ccl4, Siva1, Saa3, Malt1, Pycard
Tumor necrosis factor (TNF
superfamily, member 2)
2,77 E 205 Cd14, Cd83, Aif1, Litaf, S100a6, Nfkbia, H2-Ab1, Cxcl1,
Ctsd, Il1b, Tnfrsf1b, Nfkbib, Ccl4, Saa3, Socs3, Erg
Spleen tyrosine kinase 1,11 E 204 Tyrobp, Sla, Lgals1, Fcgr1, Cmtm7, Ptprc, Fcer1g, Trem2,
Egr2
Caspase 1,84 E 203 Lgals1, Plp1, Ctsd, Afp, Ctsc, B2m, Siva1, Malt1, Pycard,
Creg1
Chemokine (CC MOTIF)
ligand 2
2,52 E 203 Cd14, Nfkbia, Cxcl1, Il1b, Vim, Ccl4
Interleukin 10 3,07 E 203 Cd83, Lgals1, Il1b, Etv3, Fcgr1, Trem2, Socs3
Interleukin 1 3,95 E 203 Cd14, Nfkbia, Cxcl1, Il1b, Nfkbib, Ctsc, Ptgds, Socs3,
Pycard
Interleukin 6 4,21 E 203 Grn, Cebpb, Cxcl1, Lgals3, Il1b, Gfap, Junb, Socs3
Toll-like receptor 6,94 E 203 Cd14, Cxcl1, Grk5, Anxa2, Hspe1, Ly86, Saa3, Trem2
Protein tyrosine phosphatase,
receptor type
8,19 E 203 Tyrobp, Lgals1, Ptpre, Fcgr1, Cd52, Ptprc
Pathways downregulated in reactive astrocytes at 5 days after stab wound injury
Fibroblast growth factor 8,99 E 205 Ccnd2, Syt1, Serpine2, Fgfr3, Pax6, Sdc4, Sox2, Nedd4,
Gpc5, Dmp1, Ncam1, Vegfa, Gja1, Spry2, Hip1, Hs2st1,
Gli3, Sox9, Etv4, Cyr61
Rhoa RAS homolog 4,78 E 204 Neo1, Arhgap5, Ednrb, Rock1, Gna13, Pias1, Sdc4, Ophn1,
S1pr1, Plxnb1, Rapgef3, Sox9, Sdc2, Cyr61
BETA catenin 1,75 E 203 Faf1, Tle1, Fzd4, Ppap2b, Sfrp1, Fbxw11, Rora, Sox2, Chd8,
Prdm5, Tcf7l2, Trrap, Enah, Ptn, Sox9, Sdc2, Apc, Cyr61,
Zeb1, Ptprz1
Lymphoid enhancer binding
factor 1 (TCF/LEF)
1,85 E 203 Tle1, Ppap2b, Nrarp, Sfrp1, Tcf7l2, Hipk2
Paxillin 2,00 E 203 Pld2, Gna13, Ptpn11, Adcyap1r1, Nek3, Flii, Ptprt, Hgf
Homeodomain interacting
protein kinase
4,01 E 203 Daxx, Pax6, Tcf7l2, Zbtb4, Hipk2
Wingless type 4,44 E 203 Faf1, Tnik, Tle1, Fzd4, Ppap2b, Fermt2, Znrf3, Nrarp,
Lrp4, Sfrp1, Rora, Pax6, Sox2, Chd8, Prdm5, Tcf7l2, Rhou,
Trps1, Trrap, Enah, Gli3, Sox9, Sdc2, Apc, Macf1
Progestin and ADIPOQ
receptor
7,64 E 203 Srebf1, Ppara, Paqr8, Appl2
Nuclear receptor subfamily
2, group F, member 2
8,13 E 203 Srebf1, Ppara, Paqr8, Appl2
Pathways upregulated in both the reactive astrocytes at 5 days after stab wound injury and the adult NSCs
Aurora kinase 3,03 E 203 Cdc20, Ncaph, Vim, Ccna2, Cdk1
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We note that previous studies have indicated that NSCs
activate similar pathways when exposed to injury, such as pro-
duction of chemokines, cytokines, and TLRs (Kokaia et al.,
2012; Lindvall and Kokaia, 2010; Martino and Pluchino,
2006). This is often accompanied by a switch from neurogen-
esis to gliogenesis after injury (Sierra et al., 2015), suggesting
that some of the activated pathways may also contribute to
favor the glial lineage. Intriguingly, some of this glial progeny
derived from SEZ NSCs after injury becomes migratory
toward the injury site (Benner et al., 2013), while local reac-
tive astrocytes in the cerebral cortex GM do not migrate (Bar-
dehle et al., 2013). NSC-derived reactive astrocytes may exert
beneficial functions in the injury site (Sabelstr€om et al.
2013), further emphasizing the significance of comparing the
properties and molecular signature of endogenous adult
NSCs with those of reactive astrocytes (for review, see G€otz
et al., 2015; Gregoire et al., 2015; Robel et al., 2011; Silver
and Steindler, 2009).
Galectins 1 and 3 as Necessary and Sufficient
Regulators of Reactive Astrocyte Proliferation and
Their NSC Potential
Both Galectins 1 and 3 are prominently expressed in adult
NSCs and reactive astrocytes (Beckervordersandforth et al.,
2010; Di Lella et al., 2011; Kajitani et al., 2009; Sakaguchi
et al., 2006; Yan et al., 2009), and their expression levels also
increase after other injuries, including middle cerebral artery
occlusion (MCAo) (Qu et al., 2011; Young et al., 2014;
Zamanian et al., 2012) and cancer (for review, see Camby
et al., 2006; Griffioen and Thijssen, 2014; LeMercier et al.,
2010; Newlaczyl and Yu, 2011). Interestingly, Lgals3 expres-
sion is not increased upon LPS stimulation, an injury condi-
tion with limited proliferative response of reactive astrocytes
(Zamanian et al., 2012).
Our data now show that Gal-1 and Gal-3 label a spe-
cific subset of reactive astrocytes (25%) with Gal-3 selec-
tively labeling the set of proliferating astrocytes. This
correlation was further substantiated at the functional level
using both loss- and gain-of-function experiments. Reactive
astrocyte proliferation was significantly reduced in Lgals12/2
Lgals32/2 mice, while their proliferation was increased after
treatment with Gal-1 or Gal-3 in vitro. Moreover, these
experiments demonstrate that defects in proliferation of
Lgals12/2Lgals32/2 astrocytes may not reflect developmental
defects, since they can be fully rescued by Gal-3 addition to
astrocytes from the adult cerebral cortex. The absence of
developmental contributions to the phenotype observed in
reactive astrocytes is further corroborated by normal num-
bers of S100b1 astrocytes without and with injury in the
Lgals12/2Lgals32/2 mice. In contrast to Gal-3 addition in
vitro, Gal-1 addition markedly reduces the number and pro-
liferation of microglia and astrocytes, consistent with previ-
ous in vivo application after the focal ischemia (Qu et al.,
2011). The antiproliferative effect of Gal-1 was also
observed in neuroblastoma cells (Kopitz et al., 2001) and a
panel of carcinoma cells of different origin (Fischer et al.,
2005). Gal-1 selectively increases p27 protein stability by
inhibition of the Ras-MEK-ERK cascade and induces p21
transcription via interaction with a5b1 integrin (Fischer
et al., 2005). It is thus conceivable that Gal-1-mediated
accumulation of these two potent cyclin-dependent kinase 2
TABLE 2: Continued
Signal transduction pathway
associations
P value Genes
Mixed lineage kinase 3,22 E 203 Pim1, Txn1, Gspt1, Nfkbia, Gadd45b, Anxa2
Cyclin B1 3,61 E 203 Cdc20, Pbk, Ccna2, Cdk1
Cell division cycle 2, (G1 to
S and G2 to M)
4,14 E 203 Cdc20, Pbk, Ncaph, Vim, Ccna2, Cdk1
Minichromosome mainte-
nance complex
4,49 E 203 Ppp2r3c, Ccna2, Cdk1
Cell division cycle 25C 4,78 E 203 Pim1, Ccna2, Cdk1
BUB1 mitotic checkpoint
serine/threonine kinase
5,64 E 203 Cdc20, Cdk1
Shown are the significantly (P< 0.01) enriched signal transduction pathways identified using GePS for genes significantly (FDR< 10%)
regulated in reactive relative to nonreactive astrocytes or upregulated (P< 0.01, fold change>32) in both the adult NSCs and reactive
astrocytes in comparison to nonreactive astrocytes.
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inhibitors may operate also in reactive glial cells, ultimately
arresting them in G1 phase of cell cycle. Besides regulation
of cell cycle, exogenously added Gal-1 also exerts effects
through interaction with integrins (Astorgues-Xerri et al.,
2014; Moiseeva et al., 2003), such as activating proapoptotic
a5b1-integrin signaling (Sanchez-Ruderisch et al., 2011).
Gal-1-induced apoptosis involves several intracellular media-
tors including the transcription factor AP1 and the down-
regulation of Bcl2 protein production (Hahn et al., 2004;
Rabinovich et al., 2000; Walzel et al., 2000). Taking into
account that a5b1 integrin is an important mediator of
microglial activation (Milner et al., 2007), cell surface pre-
sentation of Gal-1 may be implicated in the a5b1-integrin
signaling also leading to death of microglia, consistent with
our in vitro observations. Thus, Gal-1 addition reduces the
number of microglia, the vast majority of glial cells in the
cultures of reactive glia isolated from the stab wound injured
cerebral cortex, likely by both reducing their activation and
proliferation as well as their survival. This provides the
intriguing perspective to selectively regulate specific types of
glial cells after injury by taking advantage of the selective
effects of Gal-1 reducing microglia numbers, while Gal-3
promotes astrocyte number and proliferation.
Most importantly, our experiments in vitro reveal func-
tional divergence of Galectins, as extracellular Gal-3 can exert
a proproliferative effect on reactive astrocyte proliferation in
vitro. One mode of Gal-3 function may be to bind and/or
crosslink cell-surface glycoconjugates, influencing thereby
their activity (for review, see Liu and Rabinovich, 2005; Prig-
linger et al., 2013; Yang et al., 2008). This highlights that
Gal-1 and Gal-3 can also exert effects in a noncell-
autonomous manner on reactive astrocytes, as also microglia,
some neurons and NG2 glia express Gal-1 and Gal-3 in the
cerebral cortex GM. This is why it is important to examine
in this case mice with Galectin depletion in all cells, rather
than cell type-specific gene deletion. Gal-3 has been shown to
affect various cell cycle regulators also by intracellular func-
tion in other cell types, including upregulation of cyclin D1
through direct activation of its promoter or by its binding to
b-catenin, a known mediator of the canonical Wnt signaling
that regulates cyclin D1 and cell cycle progression (Kim
et al., 1999; Lin et al., 2002; Shimura et al., 2004). Cyclin
D1 is required for the injury-induced proliferation of glial
cells, including astrocytes (Nobs et al., 2013). Indeed, beyond
downregulation of cyclin D1 also Ki67 was reduced in
Lgals12/2Lgals32/2 reactive astrocytes (Supp. Info. Fig. 3D–
F), suggesting that Galectins may regulate cell cycle progres-
sion at the G1-S-phase transition, as shown also in other cell
types (Kim et al., 1999; Lin et al., 2002; Shimura et al.,
2004). We note that previous studies of Lgals32/2 mice did
not report reductions in reactive astrocyte proliferation in
striatum after MCAo (Young et al., 2014), suggesting that
other Galectins or co-factors may compensate loss of Lgals3,
but not the loss of both Lgals1 and Lgals3, as our results
indicate.
We found that Galectins also regulate the neurosphere-
forming capacity of reactive astrocytes: it is reduced in the
Lgals12/2Lgals32/2 mice after injury and increased upon
Gal-3, but not Gal-1 addition. Thus, Gal-3 expression is not
only shared between adult NSCs and reactive astrocytes, but
also seems to be a key factor regulating NSC properties as
reflected in the multipotency and self-renewal of the neuro-
sphere assay. Given the role of Galectins in promoting the
NSC potential of reactive astrocytes observed in our study,
future regenerative therapies may use such tools to enhance
the local stem cell pool. This is particularly promising as we
could show that extracellular addition of Gal-3 is able to pro-
mote NSC potential.
In sum, our comparative transcriptome analyses identi-
fied two Galectins not only as markers in the lesioned adult
cerebral cortex, but also as regulators of the proliferating and
neurosphere-forming capacity of a subset of reactive astro-
cytes, thereby providing a rich data source toward a better
understanding of the key factors regulating astrocyte heteroge-
neity after injury.
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